Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q2 2021 · 10-Q
Revenue$45.37M$45.37M+6.8% vs Q2 2020 Net Income-$117.32M-$117.32MN/M vs Q2 2020 EPS Diluted-$1.07-$1.07N/M vs Q2 2020 Operating Income-$88,566,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$78,929,000N/M Margins · derivedOperating margin-195.2%−67.9 pt vs Q2 2020
Net margin-258.6%−113.1 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 5, 2021 · 36 d after period end